Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is an 8-week, multicenter, open-label study in which eligible subjects with a history of
otitis media requiring TT placement will receive 6 mg OTO-201 to each ear. The study is
designed to evaluate the safety and efficacy of OTO-201 in subjects undergoing TT placement
with common concurrent surgeries and any middle ear effusion status.